Suchergebnisse - "Tondini, Carlo"

PubPharm (9)

1

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

enthalten in: The New England journal of medicine | 2022

von Tawbi, H. | Schadendorf, D. | Lipson, E. | +120

CommentIn: N Engl J Med. 2022 Jan 6;386(1):91-92. - PMID 34986291

2

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer : Final analysis of MetaPHER, a phase IIIb single-arm safety study

enthalten in: Breast cancer research and treatment | 2021

von Kuemmel, S. | Tondini, C. | Abraham, J. | +13

3

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Bachelot, T. | Ciruelos, E. | Schneeweiss, A. | +111

CommentIn: Ann Oncol. 2019 May 1;30(5):665-667. - PMID 30888412

4

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer : Long-Term Follow-Up of the BIG 1-98 Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Ruhstaller, T. | Giobbie-Hurder, A. | Colleoni, M. | +27

CommentIn: J Clin Oncol. 2019 Jun 10;37(17):1515-1516. - PMID 31034298

5

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01) : 10-year follow-up of a randomised, controlled phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von Galimberti, V. | Cole, B. | Viale, G. | +117

CommentIn: Lancet Oncol. 2018 Oct;19(10):1272-1273. - PMID 30196032

6

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer : International Breast Cancer Study Group Trial 22-00

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Colleoni, M. | Gray, K. | Gelber, S. | +19

CommentIn: J Clin Oncol. 2016 Oct 1;34(28):3369-71. - PMID 27551109

7

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT) : a combined analysis of two phase 3 randomised trials

enthalten in: The Lancet. Oncology | 2015

von Bernhard, J. | Luo, W. | Ribi, K. | +18

CommentIn: Lancet Oncol. 2015 Jul;16(7):749-51. - PMID 26092819

8

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

enthalten in: The New England journal of medicine | 2014

von Pagani, O. | Regan, M. | Walley, B. | +132

CommentIn: N Engl J Med. 2014 Jul 10;371(2):175-6. - PMID 25006724

9

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

enthalten in: Breast cancer research and treatment | 2014

von Decensi, A. | Sun, Z. | Guerrieri-Gonzaga, A. | +14

1
[1]